Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy Hideho OkadaFrank S. LiebermanIan F. Pollack Tumor Immunology: Steps And Principles Pages: 13 - 20
MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor Howard BroderAndrea AndersonLinda M. Liau Tumor Immunology: Steps And Principles Pages: 21 - 30
Robust ability of IFN-γ to upregulate class II MHC antigen expression in tumor bearing rat brains Tanya DuttaAlexander SpenceLois A. Lampson Tumor Immunology: Steps And Principles Pages: 31 - 44
Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression Robert M. PrinsMartin R. GrafChristopher J. Wheeler Tumor Immunology: Steps And Principles Pages: 45 - 54
Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium John S. YuPaul K. LeeChristopher J. Wheeler Tumor Immunology: Steps And Principles Pages: 55 - 61
Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo Timothy F. WithamLorissa VillaWilliam H. Chambers Tumor Immunology: Steps And Principles Pages: 63 - 69
Survivin in brain tumors: an attractive target for immunotherapy Masahito KatohRick WilmottePierre-Yves Dietrich Tumor Antigens: Twists And Turns Pages: 71 - 76
Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine Andrew T. ParsaJohn I. MillerJeffrey N. Bruce Tumor Antigens: Twists And Turns Pages: 77 - 87
γ Interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes David B. PaulSusana B. ReadCarol A. Kruse Tumor Antigens: Twists And Turns Pages: 89 - 99
Immunotoxin therapy for CNS tumor Edward RustamzadehWalter C. LowWalter A. Hall Tumor Antigens: Twists And Turns Pages: 101 - 116
Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma Akiva MintzDenise M. GiboWaldemar Debinski Tumor Antigens: Twists And Turns Pages: 117 - 123
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma Friedrich WeberAnthony AsherRaj K. Puri Tumor Antigens: Twists And Turns Pages: 125 - 137
Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors Roberta P. GlickTerry LichtorEdward P. Cohen Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 139 - 146
Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol H. RenT. BoulikasN. G. Rainov Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 147 - 154
Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2 Maciej S. LesniakBetty M. TylerHenry Brem Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 155 - 160
The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors Peter E. FecciDuane A. MitchellJohn H. Sampson Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 161 - 176
Human autologous dendritic cell-glioma fusions: feasibility and capacity to stimulate T cells with proliferative and cytolytic activity Andrew E. SloanPrahlad Parajuli Enhancing The Response: Immunogene Therapy And Dendritic Cell (DC) Vaccines Pages: 177 - 183